Page last updated: 2024-10-29

ifosfamide and Granulocytic Leukemia, Chronic

ifosfamide has been researched along with Granulocytic Leukemia, Chronic in 10 studies

Research Excerpts

ExcerptRelevanceReference
"Coexistence of Philadelphia chromosome (Ph)-negative, primitive hematopoietic progenitor cells with their malignant counterparts in chronic myelogenous leukemia (CML) has been reported."2.69Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML. ( Burger, KJ; Heinzinger, M; Lange, W; Rosenstiel, A; Scheid, S; Waller, CF, 1998)
"Twenty-three patients with chronic myelogenous leukemia in early chronic phase (ECP) and not previously treated with alpha-interferon (IFN-alpha) (10 patients), in ECP but pretreated with IFN-alpha (<12 months) (seven patients) and in late chronic phase (LCP) pretreated with IFN-alpha (>12 months) (six patients) underwent autografting with Philadelphia (Ph) chromosome-negative blood progenitor cells (BPCs) (20 patients), or partially/totally Ph-positive BPCs (three patients), previously mobilized during the early phase of recovery after aplasia induced by intensive chemotherapy."2.68High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. ( Benvenuto, F; Carella, AM; Carlier, P; Chimirri, F; Dejana, A; Ferrara, RA; Florio, G; Frassoni, F; Gatti, AM; Incagliato, M; Lerma, E; Piaggio, G; Pitto, A; Podestà, M; Pollicardo, N; Prencipe, E; Soracco, M; Valbonesi, M; Vassallo, F; Vimercati, R, 1996)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (80.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunbar, CE1
Nienhuis, AW1
Stewart, FM1
Quesenberry, P1
O'Shaughnessy, J1
Cowan, K1
Cottler-Fox, M1
Leitman, S1
Goodman, S1
Sorrentino, BP1
Van den Berg, D1
Wessman, M1
Murray, L1
Tong, J1
Chen, B1
Chen, S1
Simonetti, D1
King, J1
Yamasaki, G1
DiGiusto, R1
Gearing, D1
Reading, C1
Carella, AM3
Chimirri, F1
Podestà, M1
Pitto, A1
Piaggio, G1
Dejana, A1
Lerma, E1
Pollicardo, N1
Vassallo, F1
Soracco, M1
Benvenuto, F1
Valbonesi, M1
Carlier, P1
Vimercati, R1
Prencipe, E1
Gatti, AM1
Ferrara, RA1
Incagliato, M1
Florio, G1
Frassoni, F2
Boqué, C3
Petit, J2
Sarrá, J1
Cancelas, JA1
Muñoz, J1
Español, JI1
de la Banda, E1
Aventin, A2
Berlanga, J1
Ferrá, C1
Amill, B2
Torrico, C1
Azqueta, C1
Llucià, M1
García, J1
Grañena, A3
Heinzinger, M1
Waller, CF1
Rosenstiel, A1
Scheid, S1
Burger, KJ1
Lange, W1
Sureda, A2
Brunet, S1
Martino, R1
González, JR1
Larriba, I1
Blanco, A1
Martín-Henao, GA1
Sierra, J2
Salar, A1
Menéndez, B1

Reviews

1 review available for ifosfamide and Granulocytic Leukemia, Chronic

ArticleYear
[Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
    Sangre, 1998, Volume: 43, Issue:2

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Biomarkers

1998

Trials

4 trials available for ifosfamide and Granulocytic Leukemia, Chronic

ArticleYear
High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Bone marrow transplantation, 1996, Volume: 17, Issue:2

    Topics: Adult; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow;

1996
Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.
    Bone marrow transplantation, 1996, Volume: 18, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Cisplatin; Combined Modality

1996
Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML.
    Leukemia, 1998, Volume: 12, Issue:3

    Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cells, Cultured;

1998
Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
    Bone marrow transplantation, 1999, Volume: 24, Issue:12

    Topics: Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Blood Compo

1999

Other Studies

5 other studies available for ifosfamide and Granulocytic Leukemia, Chronic

ArticleYear
Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous
    Human gene therapy, 1993, Volume: 4, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Breast Neo

1993
Leukemic burden in subpopulations of CD34+ cells isolated from the mobilized peripheral blood of alpha-interferon-resistant or -intolerant patients with chronic myeloid leukemia.
    Blood, 1996, May-15, Volume: 87, Issue:10

    Topics: Adolescent; Adult; Animals; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blast Cr

1996
ICE, mini-ICE or high-dose hydroxyurea to mobilize Philadelphia (Ph1)-negative PBPC in chronic myelogenous leukaemia.
    British journal of haematology, 1996, Volume: 95, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Hematopoietic Stem Cell Transp

1996
Mini-ICE regimen allows mobilization of peripheral blood progenitor cells in a patient with chronic myelogenous leukemia failing the ICE protocol.
    Haematologica, 2000, Volume: 85, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cytarabine; Etoposide; Granulocy

2000
Mini-ice protocol is better than high-dose hydroxyurea to mobilize Ph-negative cells in earlier phases of chronic myelogenous leukemia.
    Leukemia & lymphoma, 2001, Volume: 40, Issue:3-4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Humans; Hydroxyurea; Ifosfamid

2001